B1 Non-refereed article in a scientific journal

Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma




AuthorsKalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Siru Mäkelä, Micaela Hernberg

PublisherTAYLOR & FRANCIS LTD

Publication year2019

JournalActa Oncologica

Journal acronymACTA ONCOL

Volume59

First page 310

Last page314

Number of pages5

ISSN0284-186X

eISSN1651-226X

DOIhttps://doi.org/10.1080/0284186X.2019.1670862




Last updated on 2024-26-11 at 21:56